Cite
HARVARD Citation
Geynisman, D. et al. (2013). A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma. Journal for immunotherapy of cancer. 1 (1), p. . [Online].